Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01942993
Title The Effects of Treatment With Vemurafenib on the Immune System in Advanced Melanoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Philip Friedlander
Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST